GATA6 and metastatic malignant neoplasm in the lymph nodes: High GATA6 expression correlates with better overall survival (OS) and disease-free survival (DFS), while low GATA6 expression is linked to larger tumors, a higher percentage of lymph node metastasis, and poorer differentiation.